首页|期刊导航|癌症（英文版）|Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial

Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial

Qiu‑Wen Tan Ting Luo Hong Zheng Ting‑Lun Tian Ping He Jie Chen He‑Lin Zeng Qing Lv

癌症（英文版）2017，Vol.36Issue(6)：274-281,8.

癌症（英文版）2017，Vol.36Issue(6)：274-281,8.DOI:10.1186/s40880-017-0196-5

Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial

Qiu‑Wen Tan ¹Ting Luo ²Hong Zheng ²Ting‑Lun Tian ²Ping He ²Jie Chen ¹He‑Lin Zeng ²Qing Lv¹

作者信息

1. Department of Breast Surgery, West China Hospital, Sichuan University,Chengdu 610041, Sichuan, P. R. China
2. Department of Medical Oncology,West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P. R. China
折叠

摘要

关键词

Locally advanced breast cancer/Neoadjuvant/Randomized clinical trial/Taxanes/Anthracycline/Chemotherapy

Key words

Locally advanced breast cancer/Neoadjuvant/Randomized clinical trial/Taxanes/Anthracycline/Chemotherapy

引用本文复制引用

Qiu‑Wen Tan,Ting Luo,Hong Zheng,Ting‑Lun Tian,Ping He,Jie Chen,He‑Lin Zeng,Qing Lv..Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial[J].癌症（英文版）,2017,36(6):274-281,8.

基金项目

Financial support for the tumour response surveillance portion of this prospectiverandomized trial was provided by Pfizer (WS388465) and Departmentof Science and Technology of Sichuan Province (2014SZ0190). However, theyboth had no role in the study design, data collection, data analysis, or reportwriting. （WS388465）

癌症（英文版）

OACSCDCSTPCDSCI

ISSN：1000-467X

访问量0

下载量0

段落导航